Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays.

2015-06-10
Kiriş, Erkan
Stanford, SM
Wanner, LM
Cazares, L
Maestre, MF
Du, HT
Gomba, GY
Burnett, JC
Gussio, R
Bottini, N
Panchal, RG
Kane, CD
Tessarollo, L
Bavari, S
There is an urgent need to develop novel treatments to counter Botulinum neurotoxin (BoNT) poisoning. Currently, the majority of BoNT drug development efforts focus on directly inhibiting the proteolytic components of BoNT, i.e. light chains (LC). Although this is a rational approach, previous research has shown that LCs are extremely difficult drug targets and that inhibiting multi-serotype BoNTs with a single LC inhibitor may not be feasible. An alternative approach would target neuronal pathways involved in intoxication/recovery, rather than the LC itself. Phosphorylation-related mechanisms have been implicated in the intoxication pathway( s) of BoNTs. However, the effects of phosphatase inhibitors upon BoNT activity in the physiological target of BoNTs, i.e. motor neurons, have not been investigated. In this study, a small library of phosphatase inhibitors was screened for BoNT antagonismin the context of mouse embryonic stem cell-derived motor neurons (ES-MNs). Four inhibitors were found to function as BoNT/A antagonists. Subsequently, we confirmed that these inhibitors protect against BoNT/A in a dose-dependent manner in human ES-MNs. Additionally, these compounds provide protection when administered in post-intoxication scenario. Importantly, the inhibitors were also effective against BoNT serotypes B and E. To the best of our knowledge, this is the first study showing phosphatase inhibitors as broad-spectrum BoNT antagonists.

Suggestions

Small molecule ubiquitin-proteasome system inhibitor library screen reveals botulinum neurotoxin type a inhibitors
Şen, Edanur; Kiriş, Erkan; Department of Biology (2021-2-15)
Botulinum neurotoxins (BoNTs), known as the most potent bacterial toxins, cause potentially lethal disease botulism. BoNTs are classified as category A bioterror agents by many countries because they are easy to produce and have extreme toxicities. On the other hand, BoNTs are considered a therapeutic marvel in medicine because they have been extensively utilized not only for cosmetic purposes to get rid of wrinkles but also to treat various conditions in clinics, including movement disorders. These toxins ...
In vitro anticancer effect of tricyclic antidepressant nortriptyline on multiple myeloma
BİBER, Aysenur; DURUSU, Ipek Z.; Özen, Can (2018-01-01)
Drug repurposing has been proved to be an effective strategy to meet the urgent need for novel anticancer agents for multiple myeloma (MM) treatment. In this work, we aimed to investigate the anticancer effect and mechanism of tricyclic antidepressant nortriptyline (NTP) on the U266 MM cell line. The in vitro inhibitory effect of NTP at various doses and time points was studied. The combination potential of cisplatin-NTP was also investigated. Cell cycle analysis and three flow cytometric apoptosis assays w...
Formaldehyde biosensing in air using fluorescent bacterial bioreporter cells
Elcin, Evrim; Ayaydin, Ferhan; Öktem, Hüseyin Avni (2021-11-01)
Formaldehyde is a genotoxic volatile organic pollutant and one of the causative agents of sick building syndrome. Despite of its hazardous carcinogenic effects, it has been still used in daily life products and household materials. Hence, determination of formaldehyde both in ambient air and drinking water sources is crucial to prevent its adverse health effects. Whole-cell biosensors have emerged as bio-sentinels for environmental monitoring to assess pollution in air, water and soil. Herein whole-cell bac...
Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitors
Dultz, Georg; Shimakami, Tetsuro; Schneider, Markus; Murai, Kazuhisa; Yamane, Daisuke; Marıon, Antoıne; Zeitler, Tobias M.; Stross, Claudia; Grimm, Christian; Richter, Rebecca M.; Baeumer, Katrin; Yi, MinKyung; Biondi, Ricardo M.; Zeuzem, Stefan; Tampe, Robert; Antes, Iris; Lange, Christian M.; Welsch, Christoph (2020-10-01)
Inhibitors against the NS3-4A protease of hepatitis C virus (HCV) have proven to be useful drugs in the treatment of HCV infection. Although variants have been identified with mutations that confer resistance to these inhibitors, the mutations do not restore replicative fitness and no secondary mutations that rescue fitness have been found. To gain insight into the molecular mechanisms underlying the lack of fitness compensation, we screened known resistance mutations in infectious HCV cell culture with dif...
Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity
KOÇAK ASLAN, EBRU; HAN, MUHAMMED İHSAN; Krishna, Vagolu Siva; Tamhaev, Rasoul; Dengiz, Çağatay; DOĞAN, ŞENGÜL DİLEM; Lherbet, Christian; Mourey, Lionel; Tonjum, Tone; GÜNDÜZ, MİYASE GÖZDE (2022-10-01)
Isoniazid (INH) is one of the key molecules employed in the treatment of tuberculosis (TB), the most deadly infectious disease worldwide. However, the efficacy of this cornerstone drug has seriously decreased due to emerging INH-resistant strains of Mycobacterium tuberculosis (Mtb). In the present study, we aimed to chemically tailor INH to overcome this resistance. We obtained thirteen novel compounds by linking INH to in-house synthesized sulfonate esters via a hydrazone bridge (SIH1-SIH13). Following str...
Citation Formats
E. Kiriş et al., “Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays.,” PloS one, 2015, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/41004.